James Christensen
2019
Compensation breakdown
| Non-Equity Incentive Plan | $217,500 |
|---|---|
| Option Awards | $2,637,984 |
| Salary | $435,000 |
| Other | $2,500 |
| Total | $3,292,984 |
Christensen received $2.6M in option awards, accounting for 80% of the total pay in 2019.
Christensen also received $217.5K in non-equity incentive plan, $435K in salary and $2.5K in other compensation.
Rankings
In 2019, James Christensen's compensation ranked 3,703rd out of 13,971 executives tracked by ExecPay. In other words, Christensen earned more than 73.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,703 out of 13,971 | 74th |
Division Manufacturing | 1,336 out of 5,701 | 77th |
Major group Chemicals And Allied Products | 463 out of 2,200 | 79th |
Industry group Drugs | 388 out of 1,886 | 79th |
Industry Pharmaceutical Preparations | 292 out of 1,398 | 79th |
Pay ratio
| James Christensen's Pay | $3,292,984 |
|---|---|
| Median Employee's Pay | $588,168 |
| Pay Ratio | 6to 1 |
In 2019, the annual total compensation of James Christensen was $3,292,984.
The annual total compensation of the median employee at Mirati Therapeutics was $588,168.
The ratio of James Christensen's pay to the pay of median employee was therefore 6 to one.
Christensen's colleagues
We found four more compensation records of executives who worked with James Christensen at Mirati Therapeutics in 2019.
2019
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2019
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
2019
Jamie Donadio
Mirati Therapeutics
Chief Financial Officer
2019
Chris LeMasters
Mirati Therapeutics